Loading company…
RNatives develops RNA-based gene regulation therapies for serious diseases.
RNatives develops precision RNA therapies intended to regulate gene expression and address serious diseases. The company works with pharmaceutical firms, biotech companies and healthcare institutions. Based in Kuopio, Finland, it raised EUR 14.00 mn in Seed funding on May 27, 2025, led by Nordic Science Investments, with participation from Business Finland Venture Capital and Force10.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in